Collection and concentration system for biologic substance of interest and use thereof

Patent metadata

Field	Value
Publication number	US-9494500-B2
Application number	US-201314065265-A
Country	US
Kind code	B2
Filing date	Oct 28, 2013
Priority date	Oct 29, 2012
Publication date	Nov 15, 2016
Grant date	Nov 15, 2016

Abstract

A system and method thereof for collecting and concentrating a biologic substance of interest is provided. The biologic of interest obtained from a biologic sample present at an initial low concentration (or low number counts) can be captured and released through a collection device of the system to an intermediate second concentration, and further recovered through a concentration device of the system to a third concentration, thereby facilitating subsequent detection, characterization, enumeration, immunostaining, inspection, imaging, culturing, molecular analysis, and/or other assays.

First claim

What is claimed:

1. A microfluidic flow-through system for enriching circulating tumor cells (CTCs) from a biologic sample, the system comprising:
a flow-through capture device comprising: (a) a sample inlet at a proximal end of the flow-through capture device configured to receive the biologic sample at a first concentration, (b) a fluid channel fluidly coupled to the sample inlet, wherein the fluid channel comprises one or more surfaces comprising a plurality of microstructures substantially perpendicular to a direction of bulk fluid flow and a surface coating attached to a portion of the one or more surfaces, wherein the surface coating comprises (1) a nonfouling lipid-bilayer composition, and (2) an antibody that selectively binds CTCs present within the biologic sample, and (c) an outlet at a distal end of the flow-through capture device;
a three-way valve in fluid communication with the flow-through capture device, the three-way valve comprising (a) a valve inlet fluidly coupled to the outlet of the flow-through capture device, (b) a first valve outlet for diverting away unwanted materials, and (c) a second valve outlet, wherein the three-way valve further comprises a first state and a second state, wherein in the first state, the three-way valve allows fluid flow from the flow-through capture device through the first valve outlet but not the second valve outlet, and wherein in the second state, the three-way valve allows fluid flow from the flow-through capture device through the second valve outlet but not the first valve outlet;
a flow-through concentration device in fluid communication with the three-way valve, wherein the flow-through concentration device is configured to receive the CTCs at a second concentration higher than the first concentration and concentrate the CTCs to a third concentration higher than the second concentration, wherein the flow-through concentration device comprises (a) an inlet in fluid communication with the second valve outlet of the three-way valve, (b) a concentration fluid channel comprising microfeatures arranged in a pattern that directs the CTCs towards a narrow region within the channel without directing unwanted components towards the narrow region, (c) a single well at a distal portion of the flow-through concentration device and within the narrow region of the channel, wherein the single well is located underneath a fluid flow path that leads towards (d) a sample outlet, wherein the single well is configured to entrap the CTCs flowing within the narrow region of the channel it via gravity while fluid flows over the single well via the fluid flow path towards the sample outlet, wherein a passage leading to a base of the single well is substantially perpendicular to the fluid flow path, wherein the single well is positioned toward a midline of the concentration device and the base of the single well has a substantially flat surface with an area of between about 1 mm 2 and about 100 mm 2 , and wherein the sample outlet is located at a distal end of the flow-through concentration device and is configured to allow removal of the unwanted components from the system.

2. The system of claim 1 , wherein the plurality of microstructures of the fluid channel of the flow-through capture device is arranged in one or more patterns.

3. The system of claim 2 , wherein the plurality of microstructures within the capture device is arranged in a pattern selected from the group consisting of one or more lines, a horseshoe pattern, a herringbone pattern, one or more herringbone patterned lines, one or more lines of clustered microstructures, and various combinations thereof.

4. The system of claim 1 , wherein the pattern of the microfeatures is selected from the group consisting of one or more lines, a horseshoe pattern, a herringbone pattern, one or more herringbone patterned lines, one or more lines of clustered microfeatures, and various combinations thereof.

5. The system of claim 1 , wherein the single well is located near the sample outlet.

6. The system of claim 1 , wherein one or more surfaces of the concentration device comprise one or more filtration elements.

7. The system of claim 6 , wherein at least one membrane-filtration element of the concentration device comprises a filtration membrane sandwiched between two adjacent chambers surrounded by one or more chamber walls being made of a material selected from the group consisting of polydimethyl-siloxane (PDMS), polymethyl methacrylate (PMMA), polyethylene (PE), polycarbonate (PC), polystyrene (PS), cyclic olefin copolymer (COC), silicon, glass, thermoplastics materials, and combinations thereof.

8. The system of claim 1 , wherein the concentration device further comprises one or more channels spatially arranged near the sample outlet.

9. The system of claim 4 , wherein the pattern of the microfeatures comprises one or more channels and the biologic substance of interest is carried and delivered through the channels.

10. The system of claim 4 , wherein the CTCs are carried and delivered under hydrodynamic forces to the single well.

11. The system of claim 1 , wherein the concentration device comprises a filtration element.

12. The system of claim 11 , wherein the filtration element is a filter membrane.

13. The system of claim 11 , wherein the filtration element is placed horizontally within the concentration device.

14. The system of claim 12 , wherein the filtration element is placed perpendicularly within the concentration device.

15. The system of claim 12 , wherein the filtration element is disposed adjacent to the single well.

16. The system of claim 1 , wherein the base of the single well comprises a filtration element.

17. The system of claim 16 , wherein the flow-through concentration device comprises a second sample outlet located below the base of the filtration element.

18. The system of claim 16 , wherein the flow-through concentration device comprises a second filtration element located at the sample outlet.

19. The system of claim 18 , wherein the filtration element and the second filtration element are positioned substantially perpendicular to one another.

20. The system of claim 1 , wherein the pattern is a herringbone pattern, and wherein the microfeatures are located on a top substrate of the flow-through concentration device and wherein the single well is located on a bottom substrate of the flow-through concentration device.

21. The system of claim 1 , wherein the concentration fluid channel comprises a substantially constant width from a proximal end to the distal end of the flow-through concentration device.

Assignees

• Academia Sinica

Inventors

• Chang Ying-Chih
• Hsu Chia-Hsien

Classifications

• G01N1/405 Primary

  by adsorption or absorption · CPC title

• B01L2300/163

  Biocompatibility · CPC title

• B01L3/502753

  characterised by bulk separation arrangements on lab-on-a-chip devices, e.g. for filtration or centrifugation · CPC title

• B01L3/502715

  characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces · CPC title

• B01L2200/027

  for microfluidic devices · CPC title